SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001193125-22-295392 from Arteris, Inc. (AIP) (CIK 0001667011) (AIP)

Arteris, Inc. (AIP) (CIK 0001667011)
Date: Nov. 30, 2022 · CIK: 0001667011 · Accession: 0001193125-22-295392

AI Filing Summary & Sentiment

File numbers found in text: 333-268257

Date
November 30, 2022
Author
Not clearly detected
Form
CORRESP
Company
Arteris, Inc. (AIP) (CIK 0001667011)

Letter

Arteris, Inc.

595 Millich Dr. Suite 200

Campbell, CA 95008

November 30, 2022

VIA EDGAR AND E-MAIL

United States Securities and Exchange Commission

Division of Corporation Finance

Office of Life Sciences

100 F Street, N.E.

Washington, D.C. 20549-6010

Attention: Jenny O’Shanick

Re: Arteris, Inc.

Registration Statement on Form S-3

Filed November 9, 2022

File No. 333-268257

To the addressee set forth above:

In accordance with Rule 461 under the Securities Act of 1933, as amended, we hereby request acceleration of the effective date of the Registration Statement on Form S-3 (Registration No. 333-268257) (the “Registration Statement”) of Arteris, Inc. (the “Company”). We respectfully request that the Registration Statement become effective as of 4:30 p.m., Washington, D.C. time, on December 2, 2022, or as soon as practicable thereafter, or at such other time thereafter as our counsel, Latham & Watkins LLP may request by telephone. Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Latham & Watkins LLP, by calling Phillip Stoup at (415) 395-8216 or Tess Bloom at (415) 395-8897.

Thank you for your assistance in this matter.

Very truly yours,
Arteris, Inc.

Show Raw Text
CORRESP
1
filename1.htm

CORRESP

 Arteris, Inc.

595 Millich Dr. Suite 200

Campbell, CA 95008

 November 30, 2022

VIA EDGAR AND E-MAIL

United States Securities and Exchange Commission

 Division of
Corporation Finance

 Office of Life Sciences

 100 F Street,
N.E.

 Washington, D.C. 20549-6010

 Attention: Jenny
O’Shanick

Re:
 Arteris, Inc.

Registration Statement on Form S-3

Filed November 9, 2022

File No. 333-268257

To the addressee set forth above:

 In accordance
with Rule 461 under the Securities Act of 1933, as amended, we hereby request acceleration of the effective date of the Registration Statement on Form S-3 (Registration
No. 333-268257) (the “Registration Statement”) of Arteris, Inc. (the “Company”). We respectfully request that the Registration Statement become effective as
of 4:30 p.m., Washington, D.C. time, on December 2, 2022, or as soon as practicable thereafter, or at such other time thereafter as our counsel, Latham & Watkins LLP may request by telephone. Once the Registration Statement has been
declared effective, please orally confirm that event with our counsel, Latham & Watkins LLP, by calling Phillip Stoup at (415) 395-8216 or Tess Bloom at (415)
395-8897.

 Thank you for your assistance in this matter.

Very truly yours,

Arteris, Inc.

By:

/s/ K. Charles Janac

K. Charles Janac

President and Chief Executive Officer

CC:
 Nicholas B. Hawkins, Arteris, Inc.

Jack Sheridan, Latham & Watkins LLP

Page Mailliard, Latham & Watkins LLP

Phillip S. Stoup, Latham & Watkins LLP